Cargando…
Post-exposure prophylaxis with isavuconazole after occupational exposure to Rhizopus
Invasive mucormycosis is typically seen in patients with hematological malignancies, diabetes and other conditions that affect the immune system. However, locally invasive disease can also be seen in both immunocompromised and immunocompetent hosts after trauma and direct inoculation. Since historic...
Autores principales: | Al-Obaidi, Mohanad, Younes, Pamela, Ostrosky-Zeichner, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142719/ https://www.ncbi.nlm.nih.gov/pubmed/30250744 http://dx.doi.org/10.1093/omcr/omy062 |
Ejemplares similares
-
Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance
por: Ellsworth, Misti, et al.
Publicado: (2020) -
Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data Analysis
por: Al-Obaidi, Mohanad M, et al.
Publicado: (2023) -
Cutaneous mucormycosis by Rhizopus arrhizus treated with isavuconazole as first line therapy: A case report
por: Zuglian, G., et al.
Publicado: (2019) -
Successful treatment of Rhizopus arrhizus rhino-orbital-cerebral mucormycosis with isavuconazole salvage therapy following extensive debridement
por: Miller, R.P., et al.
Publicado: (2021) -
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses
por: Thompson, George R., et al.
Publicado: (2016)